Peptidomimetic hydroxamate metalloproteinase inhibitors abrogate local and systemic toxicity induced by Echis ocellatus (saw-scaled) snake venom
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A repurposed low-specificity matrix metalloprotease inhibitor, marimastat, has shown effective neutralization of SVMP-rich venoms across multiple venomous snake species by preventing both local and systemic toxicity (53), decreasing hemotoxic venom effects (50, 51, 53, 60, 61), reducing SVMP-induced cytotoxicity (56, 60), and inhibiting extracellular matrix degradation (62).”
From Assessing Target Specificity of the Small Molecule Inhibitor MARIMASTAT to Snake Venom Toxins: A Novel Application of Thermal Proteome Profiling (2024) · cites this paper as [53]
In the citing paper
“PISA assays were performed on marimastat, an inhibitor of matrix metalloproteases that has shown significant inhibitory activity against SVMPs (50, 51, 53, 56, 60, 61, 62).”
From Assessing Target Specificity of the Small Molecule Inhibitor MARIMASTAT to Snake Venom Toxins: A Novel Application of Thermal Proteome Profiling (2024) · cites this paper as [53]
In the citing paper
“Numerous inhibitors have shown promising cross-species efficacy in vivo and in vitro (37, 50, 53, 57, 109), indicating that they may be less vulnerable to the effects of venom variation than traditional antibody-based antivenoms.”
From Assessing Target Specificity of the Small Molecule Inhibitor MARIMASTAT to Snake Venom Toxins: A Novel Application of Thermal Proteome Profiling (2024) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fox, J. W., & Serrano, S. M. T. (2005) · Toxicon · doi:10.1016/j.toxicon.2005.02.012 · Cited by 587 · cited 1×
“The most potent hemorrhagic SVMPs belong to the P-III class of these enzymes, owing to the presence of disintegrin-like and cysteine-rich domains in addition to the metalloproteinase domain (Fox and Serrano, 2005; Escalante et al., 2011).”
Background
Research works printed but not linked: 40
- Abubakar, 2010, Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria, PLoS Negl. Trop. Dis., 4, e767, 10.1371/journal.pntd.0000767 · DOI
- Angulo, 2003, Inhibitory effect of fucoidan on the activities of crotaline snake venom myotoxic phospholipases A2, Biochem. Pharmacol., 66, 1993, 10.1016/S0006-2952(03)00579-3 · DOI
- Bastos, 2016, Natural inhibitors of snake venom metalloendopeptidases: history and current challenges, Toxins, 8, 250, 10.3390/toxins8090250 · DOI
- Bode, 1993, Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins', FEBS Lett., 331, 134, 10.1016/0014-5793(93)80312-I · DOI · Paper page
- Bottomley, 1998, Matrix metalloproteinase inhibitors in arthritis, J. Enzyme Inhib., 13, 79, 10.3109/14756369809035829 · DOI
- Chacón, 2015, The lethality test used for estimating the potency of antivenoms against Bothrops asper snake venom: pathophysiological mechanisms, prophylactic analgesia, and a surrogate in vitro assay, Toxicon, 93, 41, 10.1016/j.toxicon.2014.11.223 · DOI
- Chippaux, 1998, Clinical safety of a polyvalent F(ab')2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon, Trans. R. Soc. Trop. Med. Hyg., 92, 657, 10.1016/S0035-9203(98)90802-1 · doi:10.1016/s0035-9203(98)90802-1
- Escalante, 2000, Effectiveness of batimastat, a synthetic inhibitor of matrix metalloproteinases, in neutralizing local tissue damage induced by BaP1, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper, Biochem. Pharmacol., 60, 269, 10.1016/S0006-2952(00)00302-6 · DOI
- Escalante, 2003, Pulmonary hemorrhage induced by jararhagin, a metalloproteinase from Bothrops jararaca snake venom, Toxicol. Appl. Pharmacol., 193, 17, 10.1016/S0041-008X(03)00337-5 · DOI
- Escalante, 2011, Key events in microvascular damage induced by snake venom hemorrhagic metalloproteinases, J. Proteom., 74, 1781, 10.1016/j.jprot.2011.03.026 · DOI · Paper page
- Flipo, 2009, Hydroxamates: relationships between structure and plasma stability, J. Med. Chem., 52, 6790, 10.1021/jm900648x · DOI
- Gené, 1989, Comparative study on coagulant, defibrinating, fibrinolytic and fibrinogenolytic activities of Costa Rican crotaline snake venoms and their neutralization by a polyvalent antivenom, Toxicon, 27, 841, 10.1016/0041-0101(89)90096-2 · DOI
- Gutiérrez, 2012, Improving antivenom availability and accessibility: science, technology, and beyond, Toxicon, 60, 676, 10.1016/j.toxicon.2012.02.008 · DOI · Paper page
- Gutiérrez, 1980, Mionecrosis, hemorragia y edema inducidos por el veneno de Bothrops asper en ratón blanco, Toxicon, 18, 603, 10.1016/0041-0101(80)90087-2 · DOI
- Gutiérrez, 2014, A multicomponent strategy to improve the availability of antivenom for treating snakebite envenoming, Bull. World Health Organ., 92, 526, 10.2471/BLT.13.132431 · DOI
- Gutiérrez, 1985, Neutralization of proteolytic and hemorrhagic activities of Costa Rican snake venoms by a polyvalent antivenom, Toxicon, 23, 887, 10.1016/0041-0101(85)90380-0 · DOI · Paper page
- Gutiérrez, 2007, Trends in snakebite envenomation therapy: scientific, technological and public health considerations, Curr. Pharm. Des., 13, 2935, 10.2174/138161207782023784 · DOI · Paper page
- Gutiérrez, 2005, Hemorrhage induced by snake venom metalloproteinases: biochemical and biophysical mechanisms involved in microvessel damage, Toxicon, 45, 997, 10.1016/j.toxicon.2005.02.029 · DOI · Paper page
- Gutiérrez, 2008, Snake venomics of the Lesser Antillean pit vipers Bothrops caribbaeus and Bothrops lanceolatus: correlation with toxicological activities and immunoreactivity of a heterologous antivenom, J. Proteome Res., 7, 4396, 10.1021/pr8003826 · DOI
- Gutiérrez, 2010, Snakebite envenoming from a global perspective: towards an integrated approach, Toxicon, 56, 1223, 10.1016/j.toxicon.2009.11.020 · DOI · Paper page
- Habib, 2013, Public health aspects of snakebite care in West Africa: perspectives from Nigeria, J. Venom. Anim. Toxins Incl. Trop. Dis., 19, 27, 10.1186/1678-9199-19-27 · doi:10.1186/1678-9199-19-27
- Howes, 2007, Neutralization of the haemorrhagic activities of viperine snake venoms and venom metalloproteinases using synthetic peptide inhibitors and chelators, Toxicon, 49, 734, 10.1016/j.toxicon.2006.11.020 · DOI
- Howes, 2003, The purification and partial characterisation of two novel metalloproteinases from the venom of the West African carpet viper, Echis ocellatus, Toxicon, 42, 21, 10.1016/S0041-0101(03)00096-5 · doi:10.1016/s0041-0101(03)00096-5
- Kini, 2005, The intriguing world of prothrombin activators from snake venom, Toxicon, 45, 1133, 10.1016/j.toxicon.2005.02.019 · DOI
- Kondo, 1960, Studies on the quantitative method for the determination of hemorrhagic activity of Habu snake venom, Jpn. J. Med. Sci. Biol., 13, 43, 10.7883/yoken1952.13.43 · DOI · Paper page
- Kornalik, 1975, Prothrombin activation induced by Ecarin - a prothrombin converting enzyme from Echis carinatus venom, Thromb. Res., 6, 57, 10.1016/0049-3848(75)90150-4 · DOI · Paper page
- Laustsen, 2016, From fangs to Pharmacology: the future of snakebite envenoming therapy, Curr. Pharm. Des., 22, 5270, 10.2174/1381612822666160623073438 · DOI · Paper page
- Lewin, 2016, Varespladib (LY315920) appears to be a potent, broad-spectrum, inhibitor of snake venom phospholipase A2 and a possible pre-referral treatment for envenomation, Toxins, 8, 248, 10.3390/toxins8090248 · DOI · Paper page
- Murakami, 2005, Inhibition of myotoxic activity of Bothrops asper myotoxin II by the anti-trypanosomal drug suramin, J. Mol. Biol., 350, 416, 10.1016/j.jmb.2005.04.072 · DOI
- Nishida, 1995, cDNA cloning and deduced amino acid sequence of prothrombin activator (ecarin) from Kenyan Echis carinatus venom, Biochemistry, 34, 1771, 10.1021/bi00005a034 · DOI
- Ownby, 1984, A new method for quantitating hemorrhage induced by rattlesnake venoms: ability of polyvalent antivenom to neutralize hemorrhagic activity, Toxicon, 22, 227, 10.1016/0041-0101(84)90023-0 · doi:10.1016/0041-0101(84)90023-0
- Rao, 2005, Recent developments in the design of specific matrix metalloproteinase inhibitors aided by structural and computational studies, Curr. Pharm. Des., 11, 295, 10.2174/1381612053382115 · DOI · Paper page
- Rucavado, 2000, Inhibition of local hemorrhage and dermonecrosis induced by Bothrops asper snake venom: effectiveness of early in situ administration of the peptidomimetic metalloproteinase inhibitor batimastat and the chelating agent CaNa2EDTA, Am. J. Trop. Med. Hyg., 63, 313, 10.4269/ajtmh.2000.63.313 · DOI · Paper page
- Soares, 2005, Medicinal plants with inhibitory properties against snake venoms, Curr. Med. Chem., 12, 2625, 10.2174/092986705774370655 · DOI · Paper page
- Theakston, 1983, Development of simple standard assay procedures for the characterization of snake venom, Bull. World Health Organ., 61, 949
- Wagstaff, 2009, Combined snake venomics and venom gland transcriptomic analysis of the ocellated carpet viper, Echis ocellatus, J. Proteom., 71, 609, 10.1016/j.jprot.2008.10.003 · DOI
- Wang, 2004, A novel P-I class metalloproteinase with broad substrate-cleaving activity, agkislysin, from Agkistrodon acutus venom, Biochem. Biophys. Res. Commun., 324, 224, 10.1016/j.bbrc.2004.09.031 · doi:10.1016/j.bbrc.2004.09.031
- Warrell, 1974, Bites by the saw-scaled or carpet viper (Echis carinatus): trial of two specific antivenoms, Br. Med. J., 4, 437, 10.1136/bmj.4.5942.437 · DOI
- Yamada, 1997, Purification and characterization of a Ca2+-dependent prothrombin activator, multactivase, from the venom of Echis multisquamatus, J. Biochem., 122, 991, 10.1093/oxfordjournals.jbchem.a021862 · doi:10.1093/oxfordjournals.jbchem.a021862
- Yamada, 1996, Isolation and characterization of carinactivase, a novel prothrombin activator in Echis carinatus venom with a unique catalytic mechanism, J. Biol. Chem., 271, 5200, 10.1074/jbc.271.9.5200 · DOI
Cited by
Williams, D. J., Faiz, M. A., Abela-Ridder, B., Ainsworth, S., Bulfone, T. C., Nickerson, A. D., Habib, A. G., Junghanss, T., Fan, H. W., Turner, M., et al. (2019) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0007059 · Cited by 447
Bittenbinder, M. A., van Thiel, J., Cardoso, F. C., Casewell, N. R., Gutiérrez, J.-M., Kool, J., & Vonk, F. J. (2024) · Communications Biology · doi:10.1038/s42003-024-06019-6 · Cited by 132
Self-citationGutiérrez, J. M., Lewin, M. R., Williams, D. J., & Lomonte, B. (2020) · Toxins · doi:10.3390/toxins12020131 · Cited by 92
“In this regard, the search for inhibitors that have been developed for diseases whose pathogenesis is associated with endogenous enzymes, such as PLA2s and metalloproteinases, represents a potentially cost- and development time-efficient piggy-back approach by taking advantage of previous preclinical and clinical asse…”
BackgroundSelf-citationSnake Antivenom: Challenges and Alternate Approaches
Alangode, A., Rajan, K., & Nair, B. G. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114135 · Cited by 88
Hall, S. R., Rasmussen, S. A., Crittenden, E., Dawson, C. A., Bartlett, K. E., Westhorpe, A. P., Albulescu, L.-O., Kool, J., Gutiérrez, J. M., & Casewell, N. R. (2023) · Nature Communications · doi:10.1038/s41467-023-43510-w · Cited by 63
Self-citation
Metadata
- Authors
- Arias, A. S., Rucavado, A., & Gutiérrez, J. M.
- Venue
- Toxicon
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 132
- Pages
- 40-49
- ISSN
- 0041-0101
- Cited by
- 90
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- Universidad de Costa Rica (741-B5-285)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Peptidomimetic hydroxamate metalloproteinase inhibitors abrogate local and systemic toxicity induced by Echis ocellatus (saw-scaled) snake venom. https://app.cochat.ai/papers/10.1016/j.toxicon.2017.04.001
- The paper
- Arias, A. S., Rucavado, A., & Gutiérrez, J. M. (2017). Peptidomimetic hydroxamate metalloproteinase inhibitors abrogate local and systemic toxicity induced by Echis ocellatus (saw-scaled) snake venom. Toxicon. https://doi.org/10.1016/j.toxicon.2017.04.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.